Antiphospholipid antibodies (aPL) are associated with an increased incidence of fetal loss, but the pathophysiology remains unclear. One mechanism may involve the binding of aPL directly to the placenta where they may initiate placental thrombosis and infarction. We have developed an immunofiuorescent technique to detect human aPL binding to human placenta. Endogenous immunoglobulins were eluted by extensive washing and residual staining was prevented by incorporating multiple blocking steps. APL were affinity purified on both cardiolipin and phosphatidylserine liposomes from the sera of six patients with aPL (five antiphospholipid syndrome (APS) patients and one post bone marrow transplant patient). Heterogeneous binding to normal term placenta, involving either the trophoblast microvillous surface, stromal and perivascular regions was demonstrated by affinity purified aPL from five of six patients. Preliminary sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting studies have demonstrated that aPL bind a number of placental proteins. b2GPI was not the predominant protein bound by aPL using this technique. This study provides further evidence for the involvement of aPL in mediating placental damage.
Lockshin MD , Druzin ML , Goei S et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus . N Eng J Med1985;313: 152–156 .
2.
Barbui T , Cortelazzo S , Galli M et al. Antiphospholipid antibodies in early repeated abortions:a case-controlled study . Fertil Steril1988;50: 589–592 .
3.
Lockshin MD . Pathogenesis of the antiphospholipid antibody syndrome . Lupus1996;5: 404–408 .
4.
Chamley LW , Pattison NS , McKay EJ . Elution of anticardiolipin antibodies and their cofactor beta-2-glycoprotein 1 from the placentae of patients with a poor obstetric history . J Reprod Immunol1993;25: 209–220 .
5.
Katano K , Aoki K , Ogasawara M et al. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPLpositive sera . Lupus1995;4: 304–308 .
Vogt E , Ng AK , Rote NS . A model for the antiphospholipid antibody syndrome:monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice . Am J Obstet Gynecol1996;174: 700–707 .
8.
Katsuragawa H , Rote NS , Inoue T et al. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts . Am J Obstet Gynecol1995;172: 1592–1597 .
9.
Abramowsky CR , Vegas ME , Swinehart G , Gyves MT . Decidual vasculopathy of the placenta in lupus erythematosus . N Engl J Med1980;303: 668–672 .
10.
De Wolf F , Carreras LO , Moerman P et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant . Am J Obstet Gynecol1982;142: 829–834 .
11.
Out HJ , Kooijman CD , Bruinse HW , Derksen RH . Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies . Eur J Obstet Gynecol Reprod Biol1991;41: 179–186 .
12.
Erlendsson K , Steinsson K , Johannsson JH , Geirsson RT . Relation of antiphospholipid antibody and placental bed infiammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus . J Rheumatol1993;20: 1779–1785 .
13.
Salafia CM , Cowchock FS.Plcental pathology and antiphospholipid antibodies:a descriptive study . Am J Perinatol1997;14: 435–441 .
14.
Salafia CM , Vintzileos AM , Silberman L et al. Placental pathology of idiopathic intrauterine growth retardation at term . Am J Perinatol1992;9: 179–184 .
15.
Triplet DA . New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies . Haemostasis1994;24: 155–164 .
16.
Harris EN . Special report. The Second International Anticardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group . Am J Clin Pathol1990;94: 476–484 .
17.
Harris EN , Baguley E , Asherson RA et al. Clinical and serological features of the `antiphospholipid syndrome' . Br J Rheumatol1987;26:(Suppl 2): S19-S19 .
18.
Alving CR , Richards RL . Immune reactivities of antibodies against glycolipids (I). Properties of anti-galactocerebroside antibodies purified by a novel technique of affinity binding to liposomes . Immunochemistry1977;14: 373–381 .
19.
Leach L , Eaton BM , Firth JA , Contractor SF . Immunogold localisation of endogenous immunoglobulin-G in ultrathin frozen sections of the human placenta . Cell Tissue Res1989;257: 603–607 .
20.
Kristoffersen EK , Matre R . Co-localization of the neontal Fc gamma receptor and IgG in human placental term syncytiotrophoblasts . Eur J Immunol1996;26: 1668–1671 .
21.
Malek A , Sager R , Kuhn P et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy . Am J Reprod Immunol1996;36: 248–255 .
22.
Johnson PM , Natvig JB , Ystehede UA , Faulk WP . Immunological studies of human placentae:the distribution and character of immunoglobulins in chorionic villi . Clin Exp Immunol1977;30: 145–153 .
23.
Wood G , Reynard J , Krishnan E , Racela L . Immunobiology of the human placenta. II. Localization of macrophages, in vivo bound IgG and C3 . Cell Immunol1978;35: 205–216 .
24.
Ravirajan CT , Harmer I , McMally T et al. Phospholipid binding specificities and idiotype expression of hybridoma derived monoclonal autoantibodies from splenic cells of patients with systemic lupus erythematosus . Ann Rheum Dis1995;54: 471–476 .
25.
Rote NS , Chang J , Katsuragawa H , Ng AK , Lyden TW , Mori T . Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells . Am J Reprod Immunol1995;33: 114–121 .
26.
Rand JH , Wu XX , Guller S et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion . Am J Obsgtet Gynecol1994;171: 1566–1572 .
27.
Rand JH , Wu XX , Andree HA et al. Pregnancy loss in the antiphospholipid-antibody syndrome <Eth> a possible thrombogenic mechanism . N Engl J Med1997;337: 154–160 .
28.
Faulk WP , Labarrere CA , Carson SD . Tissue factor:identification and characterization of cell types in human placentae . Blood1990;76: 86–96 .
29.
Donohoe S , Kingdom J , Jauniaux E et al. Localization of b2GPI and annexin V in villous placenta during normal and IUGR/APS pregnancies . J Soc Gynecol Invest1998;5:(abstract 56A).
30.
Chamley LW , Allen JL , Johnson PM . Synthesis of beta2 glycoprotein 1 by the human placenta . Placenta1997;18: 403–410 .
31.
McNally T , Mackie IJ , Machin SJ , Isenberg DA . Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome . Br J Rheumatol1995;34: 1031–1036 .
32.
Martinuzzo ME , Forastiero RR , Carreras LO . Anti beta 2 glycoprotein I antibodies:detection and association with thrombosis . Br J Haematol1995;89: 397–402 .
33.
McCrae KR , DeMichele AM , Pandhi P et al. Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss . Blood1993;82: 2730–2741 .
34.
Del Papa N , Raschi E , Catelli L et al. Endothelial cells as a target for antiphospholipid antibodies:role of anti-beta 2 glycoprotein I antibodies . Am J Reprod Immunol1997;38: 212–217 .
35.
Hill MB , Phipps JL , Malia RG et al. Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS) . Clin Exp Immunol1995;102: 368–372 .
36.
Zhou Y , Fisher SJ , Janatpour M et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?J Clin Invest1997;99: 2139–2151 .
